Try our beta test site
IMPORTANT: Listing of a study on this site does not reflect endorsement by the National Institutes of Health. Talk with a trusted healthcare professional before volunteering for a study. Read more...

Ipsilateral Hepatic Vein Embolization After Portal Vein Embolization

This study has been completed.
Information provided by:
Asan Medical Center Identifier:
First received: June 16, 2008
Last updated: NA
Last verified: June 2008
History: No changes posted

Portal vein embolization (PVE) induces shrinkage of the embolized lobe and compensatory enlargement of the non-embolized lobe, but it does not always induce sufficient liver regeneration. There was no effective method to accelerate liver regeneration in addition to PVE yet.

This study intends to assess the effect of ipsilateral hepatic vein embolization (HVE) performed after Portal vein embolization (PVE) on liver regeneration. During a 1-year study period, preoperative HVE would be performed on 10 or more patients who had shown limited liver regeneration after PVE awaiting right hepatectomy. Sequential application of PVE and HVE may be safe and effective in facilitating contralateral liver regeneration by inducing more severe liver damage than PVE alone.

Condition Intervention Phase
Procedure-Related Complication
Degree of Liver Regeneration
Procedure: Right hepatic vein embolization
Phase 2
Phase 3

Study Type: Interventional
Study Design: Allocation: Non-Randomized
Intervention Model: Single Group Assignment
Masking: Open Label
Primary Purpose: Treatment
Official Title: Sequential Preoperative Ipsilateral Hepatic Vein Embolization After Portal Vein Embolization to Induce Further Liver Regeneration in Patients With Hepatobiliary Malignancy

Further study details as provided by Asan Medical Center:

Primary Outcome Measures:
  • Future remnant left liver volume on multidetector dynamic CT scans [ Time Frame: 2 weeks after HVE ]

Secondary Outcome Measures:
  • Immunohistochemical stainings [ Time Frame: during operation ]

Enrollment: 13
Study Start Date: March 2007
Study Completion Date: April 2008
Primary Completion Date: February 2008 (Final data collection date for primary outcome measure)
Arms Assigned Interventions
Active Comparator: HVE
Hepatic vein embolization after portal vein embolization
Procedure: Right hepatic vein embolization
Embolization of the right hepatic vein
Other Name: Sequential right hepatic vein embolization
No Intervention: PVE
Only portal vein embolization, historical control group

  Show Detailed Description


Ages Eligible for Study:   20 Years to 75 Years   (Adult, Senior)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No

Inclusion Criteria:

  • Patients showing small future remnant liver < 40% of whole liver volume

Exclusion Criteria:

  • Patients showing small future remnant liver > 40% of whole liver volume
  • Inoperable tumor extent
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its identifier: NCT00698880

Korea, Republic of
Asan Medical Center
Seoul, Korea, Republic of, 138-736
Sponsors and Collaborators
Asan Medical Center
Principal Investigator: Shin Hwang, MD, PhD Department of Surgery, Asan Medical Center
  More Information

Responsible Party: Shin Hwang, Asan Medical Center Identifier: NCT00698880     History of Changes
Other Study ID Numbers: Preop_PVE_HVE
Study First Received: June 16, 2008
Last Updated: June 16, 2008

Keywords provided by Asan Medical Center:
Portal vein embolization
Hepatic vein embolization
Liver regeneration processed this record on May 25, 2017